Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “cells”

914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 914
Index total 30,257
Page 30 / 39

Quick answer

This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

914 results for “cells” · 30,257 patents in full index Clear search

  1. US 7959934

    Method for rapid generation of mature dendritic cells

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted

  2. US 7947289

    Multimeric protein toxins to target cells having multiple identifying characteristics

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 24, 2011 · Expires May 19, 2031

    granted

  3. US 7906104

    Methods for detecting pancreatic beta-islet cells and diseases thereof

    The Regents of the University of California · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  4. US 7883892

    Swine multipotent adult progenitor cells

    Regents of the University of Minnesota · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

  5. US 7884178

    Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted

  6. US 7871620

    Immunoliposomes that optimize internationalization into target cells

    The Regents of the University of California · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  7. US 7850961

    Methods for targeting solid tumor stem cells in a solid tumor using a notch4 receptor antagonist

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted

  8. US 7838289

    Assay utilizing multipotent adult stem cells

    Regents of the University of Minnesota · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

  9. US 7820634

    Composition and method for production of transformed cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

  10. US 7807458

    Multilineage-inducible cells and uses thereof

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  11. US 7803558

    Modulation of aqueous humor outflow by targeting vascular-endothelial-cadherin in Schlemm's canal cells

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Sep 28, 2010 · Expires Sep 23, 2030

    granted

  12. US 7781565

    Compositions and methods related to profiling a plurality of cells based on peptide binding

    The Board of Regents of the University of Texas System · Granted Aug 24, 2010 · Expires Aug 19, 2030

    granted

  13. US 7781413

    SEMA3B inhibits tumor growth and induces apoptosis in cancer cells

    The Board of Regents of the University of Texas System · Granted Aug 24, 2010 · Expires Aug 19, 2030

    granted

  14. US 7776607

    Mammalian selenoprotein differentially expressed in tumor cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 17, 2010 · Expires Aug 12, 2030

    granted

  15. US 7776593

    Hes6 as a marker of pancreatic endocrine cells

    The Regents of the University of California · Granted Aug 17, 2010 · Expires Aug 12, 2030

    granted

  16. US 7777019

    Mutated Anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 17, 2010 · Expires Aug 12, 2030

    granted

  17. US 7745144

    Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted

  18. US 7727534

    Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted

  19. US 7722862

    Regulatory T cells suppress autoimmunity

    The Regents of the University of California · Granted May 25, 2010 · Expires May 20, 2030

    granted

  20. US 7723311

    Delivery of bioactive substances to target cells

    United States of America as represented by the Secretary of the Air Force · Granted May 25, 2010 · Expires May 20, 2030

    granted

  21. US 7718196

    Rapamycin-resistant T cells and therapeutic uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted May 18, 2010 · Expires May 13, 2030

    granted

  22. US 7713710

    Isolation and use of solid tumor stem cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 11, 2010 · Expires May 6, 2030

    granted

  23. US 7666411

    Methods of treating and preventing colitis involving IL-13 and NK-T cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 23, 2010 · Expires Feb 18, 2030

    granted

  24. US 7658923

    Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26

    The Board of Regents of the University of Texas System · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.